American Journal of Kidney Diseases
Volume 46, Issue 4 , Pages 754-759, October 2005

Nephrogenic Fibrosing Dermopathy/Nephrogenic Systemic Fibrosis: Report of a New Case With Literature Review

  • Sumanth R. Daram, MD
  • ,
  • Cherise M. Cortese, MD
  • ,
  • Bahar Bastani, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Bahar Bastani, MD, Professor of Internal Medicine, Division of Nephrology, Department of Internal Medicine, Saint Louis University School of Medicine, 3635 Vista Ave, FDT-9N, St Louis, MO 63110

Department of Internal Medicine, St Joseph Regional Medical Center and Medical College of Wisconsin, Milwaukee, WI; Department of Pathology and Department of Internal Medicine, Division of Nephrology, Saint Louis University School of Medicine, St Louis, MO

Received 10 May 2005; accepted 28 June 2005. published online 12 September 2005.

Nephrogenic fibrosing dermopathy (NFD) is a fibrosing condition of the skin that is being described increasingly in patients with renal diseases, many of whom are on dialysis therapy or have undergone renal transplantation. Its etiopathology is unknown, and no standard therapy currently exists. We describe a patient with NFD for whom histopathologic studies indicated that the fibrotic process affected subcutaneous tissue, striated muscles, diaphragm, pleura, pericardium, great vessels of the heart, left ventricle and septum, and tunica albuginea in addition to the dermis. Fibroblast-like cells positive for CD34 and CD45RO and scattered CD68-positive cells were found in affected tissues. The presentation of our case is unusual in that the disease process started in the lower abdomen and upper extremities and involved the upper extremities to a greater extent than the lower extremities. Our findings indicate that the fibrosis associated with NFD can extend beyond dermis and, as part of a systemic fibrosing disorder, can involve subcutaneous tissues, striated muscles, diaphragm, pleura, pericardium, and myocardium. We therefore suggest that “nephrogenic systemic fibrosis” would be a more appropriate term for this disease entity.

Index words:  Dialysis , end-stage renal disease (ESRD) , fibrosis , nephrogenic fibrosing dermopathy (NFD) , systemic fibrosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi:10.1053/j.ajkd.2005.06.024 on September 7, 2005.The authors have no commercial or proprietary interest in any drug, device, or equipment that may have been mentioned in the following article.

PII: S0272-6386(05)01046-2

doi:10.1053/j.ajkd.2005.06.024

Refers to article:

  • Nephrogenic Systemic Fibrosis: The Nosological and Conceptual Evolution of Nephrogenic Fibrosing Dermopathy , 12 September 2005

    Shawn E. Cowper
    American Journal of Kidney Diseases October 2005 (Vol. 46, Issue 4, Pages 763-765)

American Journal of Kidney Diseases
Volume 46, Issue 4 , Pages 754-759, October 2005